OR WAIT null SECS
September 18, 2025
Article
This analysis highlights the safety and efficacy of JAK3/TEC inhibition in cicatricial alopecias, presented at EADV.
September 13, 2025
This review highlights several evidence-based approaches to promoting skin longevity and preventing signs of aging.
September 12, 2025
Video
These interviews with Chovatiya and Stein Gold highlight a variety of key points from the dermatology-centric EADV Congress 2025 meeting in Paris, France.
September 09, 2025
A look at 13 phase 2 and phase 3 studies with significant implications from EADV 2025's late-breaking sessions.
Intralesional triamcinolone showed significantly greater hair regrowth and patient satisfaction.
September 04, 2025
Amlitelimab met its primary and key secondary endpoints in the COAST 1 phase 3 study of adults and adolescents with atopic dermatitis.
September 03, 2025
This study highlighted VTE risk factors in a cohort of patients with alopecia areata who were eligible for baricitinib treatment.
September 02, 2025
September 01, 2025
This Month in Review summary includes a list of some of the most notable stories in the dermatology field from August 2025.
August 26, 2025
In this analysis, a variety of alternative therapies for hair loss, such as oils, stem cells, and laser treatments, were highlighted for their potential.
